Correlation Between Milestone Pharmaceuticals and ABPRO P
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and ABPRO P at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and ABPRO P into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and ABPRO P, you can compare the effects of market volatilities on Milestone Pharmaceuticals and ABPRO P and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of ABPRO P. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and ABPRO P.
Diversification Opportunities for Milestone Pharmaceuticals and ABPRO P
-0.7 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Milestone and ABPRO is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and ABPRO P in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ABPRO P and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with ABPRO P. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ABPRO P has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and ABPRO P go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and ABPRO P
Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to generate 0.36 times more return on investment than ABPRO P. However, Milestone Pharmaceuticals is 2.8 times less risky than ABPRO P. It trades about 0.3 of its potential returns per unit of risk. ABPRO P is currently generating about -0.5 per unit of risk. If you would invest 143.00 in Milestone Pharmaceuticals on August 30, 2024 and sell it today you would earn a total of 44.00 from holding Milestone Pharmaceuticals or generate 30.77% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 95.65% |
| Values | Daily Returns |
Milestone Pharmaceuticals vs. ABPRO P
Performance |
| Timeline |
| Milestone Pharmaceuticals |
| ABPRO P |
Milestone Pharmaceuticals and ABPRO P Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Milestone Pharmaceuticals and ABPRO P
The main advantage of trading using opposite Milestone Pharmaceuticals and ABPRO P positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, ABPRO P can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ABPRO P will offset losses from the drop in ABPRO P's long position.The idea behind Milestone Pharmaceuticals and ABPRO P pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |